Alliance HealthCare Services, Inc. (NASDAQ:AIQ) has been upgraded to Hold in a statement by TheStreet earlier today.
- Updated: October 3, 2016
TheStreet has upgraded Alliance HealthCare Services, Inc. (NASDAQ:AIQ) to Hold in a statement released on 09/30/2016.
Having a price of $7.03, Alliance HealthCare Services, Inc. (NASDAQ:AIQ) traded 2.48% higher on the day. With the last close up 6.85% from the two hundred day average, compared with the Standard & Poor's 500 Index which has decreased -0.01% over the same period. AIQ has recorded a 50-day average of $6.41 and a two hundred day average of $6.58. Trade Volume was up over the average, with 22,440 shares of AIQ changing hands over the typical 21,744
See Chart Below
Alliance HealthCare Services, Inc. has a 52 week low of $5.73 and a 52 week high of $10.92 with a PE ratio of 9.24 Alliance HealthCare Services, Inc.’s market capitalization is currently $0.
About Alliance HealthCare Services, Inc. (NASDAQ:AIQ)
Alliance HealthCare Services, Inc. (Alliance) is a provider of outsourced healthcare services to hospitals and providers. The Company operates through three segments: Radiology Division, Oncology Division and Interventional Healthcare Services Division. The radiology segment comprises diagnostic imaging services, including magnetic resonance imaging (MRI), positron emission tomography/computed tomography (PET/CT) and other imaging services. The radiology segment also comprises radiation oncology services. The interventional healthcare services segment provides interventional healthcare through therapeutic minimally invasive pain management procedures medical management, laboratory testing and other services. The Company operates freestanding outpatient radiology, oncology and interventional clinics, and Ambulatory Surgical Centers (ASC) that are not owned by hospitals or providers. It operates over 560 diagnostic imaging and radiation therapy systems.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.